The report titled “Global Glaucoma Treatment Market: Trends and Opportunities (2014-2019)” provides an insight into the glaucoma treatment market over the years with a special focus on major categories- pharmaceuticals and devices. The report includes detailed information on market size and share by type of drugs in glaucoma treatment sector. It also discusses key growth drivers, challenges and trends of the market. Further, companies like Pfizer Inc, Merck & Co, Allergan Inc and Alcon (Division of Novartis) are profiled in the report.?
- The US - Japan
- Pfizer Inc, - Merck & Co, - Allergan Inc and - Alcon (Division of Novartis)
Glaucoma, the second most common cause of blindness worldwide is generally characterized by relatively high intraocular pressure (IOP) as a result of impaired drainage of fluid, known as aqueous humor, from the eye. Currently approved treatments for glaucoma include a number of pharmaceutical drugs, laser therapies and surgical procedures. Glaucoma treatment forms a significant portion of the overall eye care market. The market for glaucoma treatment has grown rapidly in the last decade, based on both increasing number of people with glaucoma and the introduction of new treatments. However, the worldwide glaucoma treatment market is expected to decline that can be attributable to price reduction of drugs due to generic availability of many brands in coming years.
The glaucoma pharmaceuticals are segmented into two classes namely prostaglandins analogues (PGAs) and Non PGAs that include beta blockers, carbonic anhydrase inhibitors and alpha agonists. PGAS are the most widely prescribed drug class for glaucoma with latanoprost (brand name Xalatan) the most commonly prescribed drug.
Key growth drivers of the market include rising ageing population, healthcare expenditures, medical coverage and new innovative combination drugs. The market players in medication as well as devices segments are totally different and somewhat very fragmented. Leaders in glaucoma medication space include Pfizer Inc, Alcon Inc. (Novartis), Allergan Inc and Merck and Co, Inc. Companies developing glaucoma drug-delivery devices include Ocular Therapeutix Inc, QLT Inc, pSivida Corp, Icon Bioscience Inc, Amorphex Therapeutics LLC, Euclid Systems Corp and Replenish Inc. In glaucoma laser market, top market leaders include Ellex, Lumenis, Quantel and Lightmed.
Our reports have been used by over 10K customers, including:
256 pages •
By The Business Research Company
• Mar 2021
Non-Contact Infrared Thermometers Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global non-contact infrared thermometers market as it emerges from the COVID 19 shut down. Description: Where...
282 pages •
By The Business Research Company
• Mar 2021
Value Based Care Payment Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global value based care payment market as it emerges from the COVID-19 shut down. Description: Where...
Step by step: An aging US population and a rising prevalence of diabetes are expected to boost industry demand Abstract Podiatrists in the US Over the five years to 2019, the Podiatrists industry has stepped in the right direction. Revenue growth has been supported by the aging US population and the...
Help on demand: A growing elderly population will likely continue to boost the number of emergency visits Abstract Ambulance Services in the US The Ambulance Services industry exhibited growth over the five years to 2019, driven by demographic shifts. Over the five years to 2024, industry revenue is...
Apple a day: Many operators will likely engage in mergers and acquisitions to achieve economies of scale Abstract Healthcare and Social Assistance in the US The Healthcare and Social Assistance sector has steadily grown over the past five years. The majority of services offered by subsectors in the...
Hay fever: Increased funding for Medicare and Medicaid will likely support revenue growth Abstract Allergists The Allergists industry has recently benefited from strong demand growth, despite some significant revenue fluctuations over the past five years. Allergists experience a constant stream of demand...
Bed rest: The expanding coverage of industry services will likely drive revenue growth Abstract Alternative Healthcare Providers in the US The Alternative Healthcare Providers industry is characterized by a low level of market share concentration. The top two players in the industry, which include...
On the mend: A sustained influx of patients from expanded healthcare coverage will likely bolster revenue Abstract Psychiatric Hospitals in the US The Psychiatric Hospitals industry is made up of hospitals that specialize in the treatment of mental illness and behavioral health. The industry is mainly...
The major factors attributing to the growth of the Infertility Treatment Devices market are significant changes in lifestyle which contributed to the rise in infertility and prevalence of conditions such as Polycystic Ovary Syndrome (PCOS). Also, a constant increase in the incidence of infertility in both sexes is projected to drive the market....
Checking in: State operators are expected to benefit from the state’s aging population Abstract Specialist Doctors in Georgia A specialist doctor is a physician whose practice is limited to a particular branch of medicine or surgery. The Specialist Doctors industry in Georgia includes establishments...
Health Provider Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.